Back to search results
NCT06266793

Comparison of Holmium Laser and Thulium Laser for Mini PCNL

Enrolling by Invitation
NAAges 21–90InterventionalTreatment
MaineHealth
~52 participants
Updated 2024-05-23 on ClinicalTrials.gov
What's tested:Holmium LaserThulium Laser

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Laser Treatment Time
Measured over The duration of the procedure

Conditions

Nephrolithiasis
Percutaneous Nephrolithotomy

Explore related trials

Nephrolithiasis

Where it's being run

1 sites across 1 states
Maine1

Study leadership

  • David W Sobel, MD · PRINCIPAL_INVESTIGATOR · MaineHealth

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Scheduled to undergo mini PCNL for nephrolithiasis
Stone burden (multiple stones acceptable) with largest stone 1cm - 3 cm in greatest dimension on bone window of noncontrast CT within a 6 month preoperative period.
Able to give informed consent
Age 21 or older
Untreated urinary tract infections
Uncontrolled bleeding disorder and coagulopathy
Abnormal upper tract anatomy such as presence of ureteral strictures or complete ureteropelvic junction (UPJ) obstruction
Patients with urinary diversion such as ileal conduit or neobladder
Any preexisting medical condition or situation that, in the investigator's opinion, could put the participant at significant risk, confound the study results, or interfere significantly with the participants' participation in the study
Are currently prescribed buprenorphine or methadone, or carry active diagnosis of chronic opioid use disorder

Exclusion

Patients scheduled to undergo concurrent non-PCNL procedure such as contralateral ureteroscopy
Inability to give informed consent
Age less than 21
Body Mass Index (BMI) \>45
Pregnant or breastfeeding patients

What this trial measures

  • Laser Treatment TimeThe duration of the procedure

    Measured in minutes and seconds. Total laser treatment time will be total cumulative lasing time.